Publications-2019

2/6/2019

 

 

177Lu-DOTATATE and 177Lu-prostate-specific membrane antigen therapy in a patient with advanced metastatic radioiodine-refractory differentiated thyroid cancer after failure of tyrosine kinase inhibitors treatment.

Assadi M, Ahmadzadehfar H.

World J Nucl Med. 2019 Dec 18;18(4):406-408.

 

Advanced modalities of molecular imaging in precision medicine for musculoskeletal malignancies.

Jokar N, Velez E, Shooli H, Dadgar H, Sadathosseini SA, Assadi M, Gholamrezanezhad A.

World J Nucl Med. 2019 Dec 18;18(4):345-350.

 

Radioimmunotherapy (RIT) in Brain Tumors.

Gholamrezanezhad A, Shooli H, Jokar N, Nemati R, Assadi M.

Nucl Med Mol Imaging. 2019 Dec;53(6):374-381.

 

Application of [68Ga]PSMA PET/CT in Diagnosis and Management of Prostate Cancer Patients.

Dadgar H, Emami F, Norouzbeigi N, Vafaee MS, Jafari E, Gholamrezanezhad A, Assadi M, Ahmadzadehfar H.

Mol Imaging Biol. 2019 Nov 22.

 

177Lu-PSMA and 177Lu-DOTATATE Therapy in a Patient With Metastatic Castration-Resistant Prostate Cancer and Neuroendocrine Differentiation.

Assadi M, Pirayesh E, Rekabpour SJ, Zohrabi F, Jafari E, Nabipour I, Esmaili A, Amini A, Ahmadzadehfar H.

Clin Nucl Med. 2019 Oct 23.

 

177Lu-PSMA and 177Lu-DOTATATE Therapy in a Patient With Metastatic Castration-Resistant Prostate Cancer and Neuroendocrine Differentiation.

Assadi M, Pirayesh E, Rekabpour SJ, Zohrabi F, Jafari E, Nabipour I, Esmaili A, Amini A, Ahmadzadehfar H.

Clin Nucl Med. 2019 Dec;44(12):978-980.

 

An update on PET-based molecular imaging in neuro-oncology: challenges and implementation for a precision medicine approach in cancer care.

Shooli H, Dadgar H, Wáng YJ, Vafaee MS, Kashuk SR, Nemati R, Jafari E, Nabipour I, Gholamrezanezhad A, Assadi M, Larvie M.

Quant Imaging Med Surg. 2019 Sep;9(9):1597-1610.

 

Neurological manifestations related to Crohn's disease: a boon for the workforce.

Nemati R, Mehdizadeh S, Salimipour H, Yaghoubi E, Alipour Z, Tabib SM, Assadi M.

Gastroenterol Rep (Oxf). 2019 Aug;7(4):291-297.

 

Scintigraphic evaluation of remote pre-conditioning protection against unilateral renal ischemia/reperfusion injury in rats: a longitudinal study.

Sedaghat Z, Fatemikia H, Tanha K, Zahiri M, Assadi M.

Int Urol Nephrol. 2019 Nov;51(11):2083-2089.

 

Updates on 18F-FDG-PET/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring.

Yu WY, Lu PX, Assadi M, Huang XL, Skrahin A, Rosenthal A, Gabrielian A, Tartakovsky M, Wáng YXJ.

Quant Imaging Med Surg. 2019 Jun;9(6):1132-1146.

 

Significance of Microalbuminuria in Predicting Silent Myocardial Ischemia in Patients with Type 2 Diabetes Using Myocardial Perfusion Imaging

Emami T, Naeimei Z, Salehifard A, Azizmohammadi Z, Iranpour D, Kalantarhormozi M, Jafari E, Gholamrezanezhad A, Assadi M.

Mol Imaging Radionucl Ther. 2019 Jun 24;28(2):62-68.

 

Shifting paradigms in the management of pediatric differentiated thyroid cancer from static to dynamic risk stratification: a step forward toward precision medicine.

Ajdari SE, Shafiei B, Motazedian M, Qutbi M, Esmaeilzadeh P, Asli IN, Javadi H, Assadi M.

Nuklearmedizin. 2019 Jun;58(3):249-257.

 

PET Imaging of Peripheral Nerve Tumors.

Assadi M, Velez E, Najafi MH, Matcuk G, Gholamrezanezhad A.

PET Clin. 2019 Jan;14(1):81-89.

 

Hot Topics of Research in Musculoskeletal Imaging: PET/MR Imaging, MR Fingerprinting, Dual-energy CT Scan, Ultrashort Echo Time.

Kooraki S, Assadi M, Gholamrezanezhad A.

PET Clin. 2019 Jan;14(1):175-182.

 

The need for standardization of nuclear cardiology reporting and data system (NCAD-RADS): Learning from coronary artery disease (CAD), breast imaging (BI), liver imaging (LI), and prostate imaging (PI) RADS.

Assadi M, Velez E, Najafi MH, Gholamrezanezhad A.

J Nucl Cardiol. 2019 Apr;26(2):660-665.


تاریخ بروز رسانی:   14 ارديبهشت 1399

Visit Count:   1

 


Print
< >
University Affiliation Address:
دانشگاه علوم پزشکی بوشهر، بوشهر ، ایران
Bushehr University of Medical Sciences, Bushehr, Iran